The PE Ratio as of November 2024 (TTM) for Akebia Therapeutics, Inc. (AKBA) is -8.55

According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.55. This represents a change of -141.86% compared to the average of 20.42 of the last 4 quarters.

Akebia Therapeutics, Inc. (AKBA) Historical PE Ratio (quarterly & annually)

How has AKBA PE Ratio performed in the past?

The mean historical PE Ratio of Akebia Therapeutics, Inc. over the last ten years is -3.63. The current -8.55 PE Ratio has changed 23.44% with respect to the historical average. Over the past ten years (40 quarters), AKBA's PE Ratio was at its highest in in the December 2023 quarter at 95.88. The PE Ratio was at its lowest in in the September 2017 quarter at -9.98.

Akebia Therapeutics, Inc. (AKBA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Akebia Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akebia Therapeutics, Inc. (AKBA) Average PE Ratio

How has AKBA PE Ratio performed in the past?

The current PE Ratio of Akebia Therapeutics, Inc. (AKBA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Akebia Therapeutics, Inc. (AKBA) PE Ratio vs. Peers

How is AKBA’s PE Ratio compared to its peers?

Akebia Therapeutics, Inc.’s PE Ratio is greater than Protalix BioTherapeutics, Inc. (-12.94), less than Cidara Therapeutics, Inc. (-1.10), less than X4 Pharmaceuticals, Inc. (-4.05), less than Seres Therapeutics, Inc. (-4.61), less than AVROBIO, Inc. (2.07), less than CohBar, Inc. (-0.12), less than Ocean Biomedical, Inc. (-0.71), less than Enveric Biosciences, Inc. (-0.29), less than Elevation Oncology, Inc. (-0.85), less than Hepion Pharmaceuticals, Inc. (-0.20),

Build a custom stock screener for Akebia Therapeutics, Inc. (AKBA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akebia Therapeutics, Inc. (AKBA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.